Treatments & Surgery
Share your love
Tenpoint and Visus Merge to Advance Eye Care
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respective ophthalmic therapeutic assets to form a unified entity focused on addressing ocular conditions associated with aging, including presbyopia, cataracts, and geographic atrophy. Key Therapeutics in the Combined…
ViaLase, Moran Eye Center Collaborate on Glaucoma
ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. This collaboration aims to accelerate glaucoma research by utilizing Moran’s state-of-the-art…
First Inverted Meniscus Optics IOLs by Voptica
*This exclusive article is sponsored by Voptica. The opinions expressed in this article are the sponsor’s own. Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at…
Yamane Technique – Intrascleral IOL Fixation
In cataract surgery, the optimal outcome involves implanting an intraocular lens (IOL) within the capsular bag. However, complications such as posterior capsule rupture, congenital lens anomalies, or traumatic injuries can leave patients without adequate capsular support, resulting in aphakia—a condition…
Researchers Find 101 Genetic Links to Cataracts
In the largest genetic study on cataracts to date, researchers from QIMR Berghofer Medical Research Institute have identified 101 genetic regions associated with an increased risk of developing cataracts. This groundbreaking study analyzed DNA from over 950,000 individuals, providing significant…
Blood Pressure Variability Tied to Glaucoma Vision Loss
A study led by researchers at the University of California, San Diego, reveals that long-term variability in blood pressure is associated with an accelerated decline in peripheral vision caused by glaucoma progression. The findings highlight the role of vascular factors…
ESCRS 2024 Exclusive Insights: iNovation Day in Focus
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for an innovative event with its iNovation® Day in Barcelona, Spain, on Friday 6 September 2024 at the Fira Barcelona Gran Via. Scheduled to be held prior to…
Bimekizumab Reduces Uveitis Incidence in axSpA Patients
The study led by Matthew A. Brown, Genomics England, London, United Kingdom, and Martin Rudwaleit, Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany. Patients with axial spondyloarthritis (axSpA) treated with bimekizumab exhibited a markedly lower incidence of uveitis compared to those receiving…
Nerve Regrowth Breakthrough for Blindness
Researchers at the University of Connecticut have uncovered promising findings that may pave the way for treating a common cause of blindness. The study, published in the September issue of Experimental Neurology, demonstrates how injured optic nerves in mice can…
U.S. Glaucoma Prevalence and Risk Factors Study
A new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology, has revealed updated statistics on the prevalence of glaucoma in the United States. The research shows that approximately 4.22 million U.S. adults (1.62% of…